Código QR (código de barras bidimensional)

Clinical outcomes of pomalidomide‐based and daratumumab‐based therapies in patients with relapsed/refractory multiple myeloma: A real‐world cohort study in China

Abstract Background Comparative investigations evaluating the efficacy of pomalidomide‐based (Pom‐based) versus daratumumab‐based (Dara‐based) therapies in patients with relapsed/refractory multiple myeloma (RRMM) remain scarce, both in randomized controlled trials and real‐world studies. Methods Th...

ver descrição completa

Na minha lista:
Principais autores: Xiaoyan Han, Xincheng Jiang, Jingsong He, Gaofeng Zheng, Yaqin Xiong, Yanling Wen, Yang Yang, Donghua He, Qingxiao Chen, Yi Zhao, Yi Li, Wenjun Wu, Zhen Cai
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley 2024-05-01
coleção:Cancer Medicine
Assuntos:
daratumumab
multiple myeloma
pomalidomide
recurrence
refractory
Acesso em linha:https://doi.org/10.1002/cam4.7232
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados